Results
Revise Search
Health Canada consultation on edible cannabis, extracts & topicals
https://policybase.cma.ca/en/permalink/policy14020
- Date
- 2019-02-20
- Topics
- Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs
- Population health/ health equity/ public health
1 document
- Policy Type
- Response to consultation
- Date
- 2019-02-20
- Topics
- Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs
- Population health/ health equity/ public health
Documents
Health Canada consultation on the impact of vaping products advertising on youth and non-users of tobacco products
https://policybase.cma.ca/en/permalink/policy14022
- Date
- 2019-03-22
- Topics
- Health care and patient safety
- Population health/ health equity/ public health
1 document
Health Canada consultation on reducing youth access and appeal of vaping products
https://policybase.cma.ca/en/permalink/policy14078
- Date
- 2019-05-24
- Topics
- Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs
- Population health/ health equity/ public health
1 document
- Policy Type
- Response to consultation
- Date
- 2019-05-24
- Topics
- Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs
- Population health/ health equity/ public health
Documents
Health Canada consultation on vaping products labelling and packaging regulations
https://policybase.cma.ca/en/permalink/policy14124
- Date
- 2019-09-05
- Topics
- Health care and patient safety
- Population health/ health equity/ public health
1 document
Health Canada consultation on potential market for cannabis health products that would not require practitioner oversight
https://policybase.cma.ca/en/permalink/policy14125
- Date
- 2019-09-03
- Topics
- Health care and patient safety
- Population health/ health equity/ public health
1 document
Regulatory framework for the mandatory reporting of adverse drug reactions and medical device incidents by provincial and territorial healthcare institutions.
https://policybase.cma.ca/en/permalink/policy11814
- Date
- 2016-01-20
- Topics
- Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs
- Health care and patient safety
1 document
Consultation on the prescription drug list: Naloxone
https://policybase.cma.ca/en/permalink/policy11847
- Date
- 2016-03-17
- Topics
- Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs
1 document
Legalization, regulation and restriction of access to marijuana
https://policybase.cma.ca/en/permalink/policy11954
- Date
- 2016-08-29
- Topics
- Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs
2 documents
Front-of-package labelling consultation
https://policybase.cma.ca/en/permalink/policy13800
Regulation of Self-Care Products in Canada
https://policybase.cma.ca/en/permalink/policy13802
- Date
- 2016-10-31
- Topics
- Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs
- Health care and patient safety
1 document
Health Canada’s Consultation on “Plain and Standardized Packaging”
https://policybase.cma.ca/en/permalink/policy13817
- Date
- 2016-08-12
- Topics
- Health care and patient safety
- Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs
1 document
